Literature DB >> 18061071

Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.

Christine M Albert1, Lawrence Rosenthal, Hugh Calkins, Jonathan S Steinberg, Jeremy N Ruskin, Paul Wang, James E Muller, Murray A Mittleman.   

Abstract

OBJECTIVES: This study examined the risk of implantable cardioverter-defibrillator (ICD) shocks for ventricular tachycardia (VT) or ventricular fibrillation (VF) associated with driving.
BACKGROUND: Concerns regarding VT/VF occurring during driving are the basis for driving restrictions in ICD patients; however, limited data are available to inform recommendations.
METHODS: This study used a prospective nested case-crossover design to compare the risk of ICD shock for VT/VF both during and up to 60 min after an episode of driving as compared with that during other activities among 1,188 ICD patients enrolled in the TOVA (Triggers of Ventricular Arrhythmia) study.
RESULTS: Over a median follow-up of 562 days, there were 193 ICD shocks for VT/VF with data on exposure to driving before ICD shock. The absolute risk of ICD shock for VT/VF within 1 h of driving was estimated to be 1 episode per 25,116 person-hours spent driving. The ICD shocks for VT/VF were twice as likely to occur within 1 h of driving a car as compared with other times (relative risk [RR] 2.24, 95% confidence interval [CI] 1.57 to 3.18). This risk was specific for shocks for VT/VF and occurred primarily during the 30-min period after driving (RR 4.46, 95% CI 2.92 to 6.82) rather than during the driving episode itself (RR 1.05, 95% CI 0.48 to 2.30).
CONCLUSIONS: Although the risk of ICD shock for VT/VF was transiently increased in the 30-min period after driving, the risk was not elevated during driving and the absolute risk was low. These data provide reassurance that driving by ICD patients should not translate into an important rate of personal or public injury.

Entities:  

Mesh:

Year:  2007        PMID: 18061071     DOI: 10.1016/j.jacc.2007.06.059

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence.

Authors:  Thomas J Grahame; Richard B Schlesinger
Journal:  Air Qual Atmos Health       Date:  2009-06-30       Impact factor: 3.763

2.  T-wave alternans, air pollution and traffic in high-risk subjects.

Authors:  Antonella Zanobetti; Peter H Stone; Frank E Speizer; Joel D Schwartz; Brent A Coull; Helen H Suh; Bruce D Nearing; Murray A Mittleman; Richard L Verrier; Diane R Gold
Journal:  Am J Cardiol       Date:  2009-06-24       Impact factor: 2.778

3.  [Fitness to drive with cardiovascular diseases : Current guidelines of the German Federal Highway Research Institute].

Authors:  W Jung; B Hajredini; V Zvereva
Journal:  Herz       Date:  2018-06       Impact factor: 1.443

4.  Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach.

Authors:  Joep Thijssen; C Jan Willem Borleffs; Johannes B van Rees; Mihály K de Bie; Enno T van der Velde; Lieselot van Erven; Jeroen J Bax; Suzanne C Cannegieter; Martin J Schalij
Journal:  Eur Heart J       Date:  2011-06-05       Impact factor: 29.983

Review 5.  Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers.

Authors:  Eiichi Watanabe; Haruhiko Abe; Shigeyuki Watanabe
Journal:  J Arrhythm       Date:  2017-03-28

6.  Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing.

Authors:  Eiichi Watanabe; Katsunori Okajima; Akira Shimane; Tomoya Ozawa; Tetsuyuki Manaka; Itsuro Morishima; Toru Asai; Masahiko Takagi; Toshihiro Honda; Atsunobu Kasai; Eitaro Fujii; Kohei Yamashiro; Ritsuko Kohno; Haruhiko Abe; Takashi Noda; Takashi Kurita; Shigeyuki Watanabe; Hiroya Ohmori; Takashi Nitta; Yoshifusa Aizawa; Ken Kiyono; Ken Okumura
Journal:  J Interv Card Electrophysiol       Date:  2017-07-20       Impact factor: 1.900

7.  Ambient and controlled exposures to particulate air pollution and acute changes in heart rate variability and repolarization.

Authors:  Susanne Breitner; Annette Peters; Wojciech Zareba; Regina Hampel; David Oakes; Jelani Wiltshire; Mark W Frampton; Philip K Hopke; Josef Cyrys; Mark J Utell; Cathleen Kane; Alexandra Schneider; David Q Rich
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

8.  Reduction in heart rate variability with traffic and air pollution in patients with coronary artery disease.

Authors:  Antonella Zanobetti; Diane R Gold; Peter H Stone; Helen H Suh; Joel Schwartz; Brent A Coull; Frank E Speizer
Journal:  Environ Health Perspect       Date:  2009-11-18       Impact factor: 9.031

9.  Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?

Authors:  S W E Baalman; J R de Groot
Journal:  Neth Heart J       Date:  2018-02       Impact factor: 2.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.